Are you an adult living with Cushing’s disease or syndrome? If so, you may qualify to take part in this study.

This study is being conducted by Trinity Life Sciences, a healthcare research and consultancy company. Trinity are conducting this study on behalf of Lundbeck, a pharmaceutical company.

What is the aim of this study?

This study aims to understand how Cushing’s disease and Cushing’s syndrome impact your life.

By taking part in this study, you can help researchers better understand what it is like to live with Cushing’s every day, and the challenges, impacts and unmet needs that you experience.

This study is specifically looking at the impact of Cushing’s disease or Cushing’s syndrome, but only Cushing’s syndrome that has not been caused by medication use. Cushing’s caused by medication use is called exogenous Cushing’s and is not included in this study.

Who can take part?

This study is being run across a number of different countries. To take part, you need to be:

  • Aged 18 or over
  • Diagnosed with Cushing’s disease or Cushing’s syndrome (not caused by medication)
  • Living in one of the following countries: UK, France, Japan, Denmark

There are a limited number of spaces available to take part. Once these spaces are filled, recruitment for the study will be closed.

What is involved?

If you express interest in the study, you will be screened to confirm you are eligible.

If you are eligible for the study, you will be invited to a one hour telephone interview. The study organisers will be in contact with you to arrange this and provide more details.

Participation in this study is voluntary and you can withdraw at any time. There are no costs to take part.

How to get involved

If you would like to get involved or learn more about this study, please contact Jaser Aslam by emailing [email protected]. Please quote the project reference number in your email – Z260500308.

How your data will be handled

This study involves providing information about yourself and how your Cushing’s diagnosis impacts you. All personal information you provide will be kept confidential, stored securely, and may be used in and for external scientific communication. Information from the interview with you will be pseudonymized and reported in aggregate; this means that your statements during the interview cannot be linked to your name or other personal data, and your identity will remain unknown.

This study complies with the European Union General Data Protection Regulation (GDPR) and follows research standards for the protection of participants.

Have you found this helpful?

If so, please support us to bring useful information to more people affected by pituitary conditions.

Give £2.00